Company intelligence / Profile preview

Genomic Medicine

Ownership: Private
Development stage: Other

Overview

Genomic Medicine is a biotechnology company focused on developing advanced genomic therapies to treat a wide range of genetic disorders and rare diseases. The company leverages its proprietary genomic medicine platform to design and deliver precise gene and cell therapies. By integrating cutting-edge genomic research with innovative delivery technologies, Genomic Medicine aims to provide transformative treatments for patients with unmet medical needs. Their approach emphasizes the development of highly targeted interventions that address the underlying genetic causes of disease.

Therapeutic areas: Rare Diseases
Modalities: Gene therapyCell therapy
Industry: Biotech

Beyond the preview

Go deeper on Genomic Medicine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genomic Medicine.

Explore the full profile